IPP Bureau
CPHI & PMEC India 2022 showcases array of machinery, ingredients and technology
By IPP Bureau - November 30, 2022
South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe
Zydus enters into BTA for purchase from Watson Pharma
By IPP Bureau - November 30, 2022
The Business Undertaking of Watson is engaged in the business of developing, manufacturing, marketing and sale of API.
Gland Pharma to buy French pharma company Cenexi
By IPP Bureau - November 30, 2022
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
AstraZeneca’s Dapagliflozin receives CDSCO approval
By IPP Bureau - November 30, 2022
Dapagliflozin reduces the risk of sustained eGFR, cardiovascular deaths and hospitalization for heart failure in adults with CKD
Zydus receives tentative approval from USFDA for Levothyroxine Sodium for Injection
By IPP Bureau - November 29, 2022
The drug will be manufactured at the group's injectable manufacturing facility at Jarod, near Vadodara, India
Infosys Foundation opens second Diabetes Reversal Counselling Centre in Nagpur
By IPP Bureau - November 29, 2022
Through lifestyle modifications, ADORE will assess the progress of patients based on parameters like reduction in blood sugar levels and weight, among others
Lupin's subsidiary MedQuimica acquires rights to nine brands from Bausch Health
By IPP Bureau - November 29, 2022
The acquired brands are well established and recognized among doctors and other members of the medical fraternity in Brazil for their reliability, safety, and trustworthiness
Granules India CFO Sandip Neogi resigns
By IPP Bureau - November 29, 2022
The company is in the process of appointing a new CFO.
Fredun Pharmaceuticals signs two large contracts
By IPP Bureau - November 29, 2022
Fredun received one-year contract worth Rs. 65 crores from a Southeast Asian country for Pharma exports
CPhI and P-MEC India sees participation of over 1500 exhibitors
By IPP Bureau - November 29, 2022
40,000 visitors and representatives of more than 80 countries set to visit the show
Azelis inaugurates pharmaceuticals & healthcare lab for APAC in India
By IPP Bureau - November 28, 2022
The pharma laboratory is fully equipped with all the machinery needed to support formulation development, resolve technical challenges, and provide customer demonstrations
Sai Life Sciences appoints Stephen Hermitage as VP, CMC
By IPP Bureau - November 28, 2022
Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.
Philips advances AI-powered diagnostic systems and transformative workflow solutions
By IPP Bureau - November 28, 2022
Latest innovations feature vendor-neutral solutions to help reduce clinical complexity and enhance operational efficiency
Japan approves ENHERTU for treatment of adult patients with HER2 positive unresectable breast cancer
By IPP Bureau - November 27, 2022
Approval broadens indication for ENHERTU to earlier use in metastatic breast cancer and requirement for confirmatory phase 3 trial
Chantal van Gils joins NDA Advisory Board as Director of Epidemiology
By IPP Bureau - November 27, 2022
She will provide strategic advice and scientific leadership to support clients in clinical development, registration strategy, submission, early post-approval strategy
